• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示植物化学物质抑制新型冠状病毒M蛋白的潜力——基于计算机模拟和细胞的方法

Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 M protein - an in silico and cell-based approach.

作者信息

Singh Khushboo, Patten J J, Dimet-Wiley Andrea, Davey Robert A, Watowich Stanley J, Chandra Amit, Leverett Jesse

机构信息

Nutrilite, Amway Corporation, Buena Park, CA, 90621, USA.

Department of Virology, Immunology, Microbiology, National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, 02118, USA.

出版信息

Sci Rep. 2025 Jul 2;15(1):22840. doi: 10.1038/s41598-025-05907-z.

DOI:10.1038/s41598-025-05907-z
PMID:40596019
Abstract

The main protease (M) of SARS-CoV-2 plays a crucial role in viral replication and is a prime target for therapeutic interventions. Phytochemicals, known for their antiviral properties, have been previously identified as potential M inhibitors in several in silico studies. However, the efficacy of these remains in question owing to the inherent flexibility of the M binding site, posing challenges in selecting suitable protein structures for virtual screening. In this study, we conducted an extensive analysis of the M binding pocket, utilizing molecular dynamics (MD) simulations, principal component analysis (PCA) and free energy landscape (FEL) to explore its conformational diversity. Based on pocket volume and shape-based clustering, five representative protein conformations were selected for virtual screening. Virtual screening of a library of ~ 48,000 phytochemicals suggested 39 phytochemicals as potential M inhibitors. Based on subsequent MM-GBSA binding energy calculations and ADMET property predictions, five compounds were advanced to cell-based viral replication inhibition assays, with three compounds (demethoxycurcumin, shikonin, and withaferin A) exhibiting significant (EC50 < 10 μm) inhibition of SARS-CoV-2 replication. Our study provides an understanding of the binding interactions between these phytochemicals and M, contributing significantly to the identification of promising M inhibitors. Furthermore, beyond its impact on therapeutic development against SARS-CoV-2, this research highlights a crucial role of proper nutrition in the fight against viral infections.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的主要蛋白酶(M)在病毒复制中起关键作用,是治疗干预的主要靶点。植物化学物质因其抗病毒特性而闻名,此前在多项计算机模拟研究中已被确定为潜在的M抑制剂。然而,由于M结合位点固有的灵活性,这些植物化学物质的功效仍存在疑问,这给虚拟筛选中合适蛋白质结构的选择带来了挑战。在本研究中,我们对M结合口袋进行了广泛分析,利用分子动力学(MD)模拟、主成分分析(PCA)和自由能景观(FEL)来探索其构象多样性。基于口袋体积和形状聚类,选择了五个代表性蛋白质构象进行虚拟筛选。对约48000种植物化学物质库的虚拟筛选表明,有39种植物化学物质为潜在的M抑制剂。基于随后的MM-GBSA结合能计算和ADMET性质预测,将五种化合物推进到基于细胞的病毒复制抑制试验,其中三种化合物(去甲氧基姜黄素、紫草素和吴茱萸次碱)对SARS-CoV-2复制表现出显著(EC50<10μm)抑制作用。我们的研究提供了对这些植物化学物质与M之间结合相互作用的理解,对有前景的M抑制剂的鉴定有重大贡献。此外,除了对SARS-CoV-2治疗开发的影响外,本研究还突出了合理营养在抗击病毒感染中的关键作用。

相似文献

1
Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 M protein - an in silico and cell-based approach.揭示植物化学物质抑制新型冠状病毒M蛋白的潜力——基于计算机模拟和细胞的方法
Sci Rep. 2025 Jul 2;15(1):22840. doi: 10.1038/s41598-025-05907-z.
2
Phytocompounds as versatile drug-leads targeting mProtease in the SARS-CoV-2 virus: insights from a molecular dynamics study.植物化合物作为针对 SARS-CoV-2 病毒中 m 蛋白酶的多功能药物先导物:来自分子动力学研究的见解。
J Biomater Sci Polym Ed. 2024 Nov;35(16):2528-2548. doi: 10.1080/09205063.2024.2385138. Epub 2024 Jul 30.
3
Discovery of Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors through Rational Design of Novel Fluorinated 1,3,4-oxadiazole Amide Derivatives: An In-Silico Study.通过新型氟化1,3,4-恶二唑酰胺衍生物的合理设计发现严重急性呼吸综合征冠状病毒2主要蛋白酶抑制剂:一项计算机模拟研究
Chem Biodivers. 2025 Jun;22(6):e202403179. doi: 10.1002/cbdv.202403179. Epub 2025 Feb 14.
4
Virtual Screening Identifies Inhibitors of SARS-CoV-2 Main Protease through Pharmacophore and Similarity Approaches.虚拟筛选通过药效团和相似性方法鉴定出新型冠状病毒主要蛋白酶的抑制剂。
Curr Pharm Des. 2025;31(18):1461-1473. doi: 10.2174/0113816128358219241210101947.
5
Evaluation of inhibition effect and interaction mechanism of antiviral drugs on main protease of novel coronavirus: Molecular docking and molecular dynamics studies.评价抗病毒药物对新型冠状病毒主蛋白酶的抑制作用及相互作用机制:分子对接和分子动力学研究。
J Mol Graph Model. 2024 Dec;133:108873. doi: 10.1016/j.jmgm.2024.108873. Epub 2024 Sep 24.
6
Amphibian-Derived Peptides as Natural Inhibitors of SARS-CoV-2 Main Protease (M): A Combined In Vitro and In Silico Approach.源自两栖动物的肽作为严重急性呼吸综合征冠状病毒2主蛋白酶(M)的天然抑制剂:体外和计算机模拟相结合的方法
Chem Biodivers. 2025 Jun;22(6):e202403202. doi: 10.1002/cbdv.202403202. Epub 2025 Feb 6.
7
K36-based inhibitor analogs as potential therapeutics against SARS-CoV-2 main protease (Mpro): a computational investigation.基于K36的抑制剂类似物作为抗SARS-CoV-2主要蛋白酶(Mpro)的潜在疗法:一项计算研究。
Sci Rep. 2025 Jun 23;15(1):20260. doi: 10.1038/s41598-025-06676-5.
8
Repurposing FDA-approved drugs for COVID-19: targeting the main protease through multi-phase approach.将美国食品药品监督管理局(FDA)批准的药物用于治疗新型冠状病毒肺炎(COVID-19):通过多阶段方法靶向主要蛋白酶。
Antivir Ther. 2024 Dec;29(6):13596535241305536. doi: 10.1177/13596535241305536.
9
Identification of potential COVID-19 Mpro inhibitors through covalent drug docking, molecular dynamics simulation, and MMGBSA calculation.通过共价药物对接、分子动力学模拟和MMGBSA计算鉴定潜在的COVID-19 Mpro抑制剂。
Sci Rep. 2025 Jul 1;15(1):20500. doi: 10.1038/s41598-025-05375-5.
10
New combined Inverse-QSAR and molecular docking method for scaffold-based drug discovery.基于骨架的药物发现的新型组合逆定量构效关系和分子对接方法。
Comput Biol Med. 2024 Sep;180:108992. doi: 10.1016/j.compbiomed.2024.108992. Epub 2024 Aug 10.

本文引用的文献

1
Screening of Potential Inhibitors Targeting the Main Protease Structure of SARS-CoV-2 via Molecular Docking, and Approach with Molecular Dynamics, RMSD, RMSF, H-Bond, SASA and MMGBSA.通过分子对接和分子动力学、RMSD、RMSF、氢键、SASA 和 MMGBSA 方法筛选针对 SARS-CoV-2 主要蛋白酶结构的潜在抑制剂。
Mol Biotechnol. 2024 Aug;66(8):1919-1933. doi: 10.1007/s12033-023-00831-x. Epub 2023 Jul 25.
2
Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19.化湿败毒方中的生物活性化合物具有抗新冠病毒和抗炎的双重作用。
Proc Natl Acad Sci U S A. 2023 May 2;120(18):e2301775120. doi: 10.1073/pnas.2301775120. Epub 2023 Apr 24.
3
Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (M) using molecular docking and deep learning methods.
利用分子对接和深度学习方法鉴定药用植物来源的植物化学物质作为 SARS-CoV-2 主蛋白酶(M)的潜在抑制剂。
Comput Biol Med. 2023 May;157:106785. doi: 10.1016/j.compbiomed.2023.106785. Epub 2023 Mar 11.
4
Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 molecular docking.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶结构的潜在抑制剂筛选:分子对接
Front Pharmacol. 2022 Oct 5;13:962863. doi: 10.3389/fphar.2022.962863. eCollection 2022.
5
The Efficacy of Traditional Medicinal Plants in Modulating the Main Protease of SARS-CoV-2 and Cytokine Storm.传统草药在调节 SARS-CoV-2 主要蛋白酶和细胞因子风暴方面的功效。
Chem Biodivers. 2022 Nov;19(11):e202200655. doi: 10.1002/cbdv.202200655. Epub 2022 Oct 10.
6
The Natural Products Withaferin A and Withanone from the Medicinal Herb Are Covalent Inhibitors of the SARS-CoV-2 Main Protease.药用植物醉茄中的天然产物醉茄内酯 A 和醉茄内脂是 SARS-CoV-2 主蛋白酶的共价抑制剂。
J Nat Prod. 2022 Oct 28;85(10):2340-2350. doi: 10.1021/acs.jnatprod.2c00521. Epub 2022 Sep 13.
7
Fragment-based design of SARS-CoV-2 Mpro inhibitors.基于片段的新型冠状病毒3C样蛋白酶抑制剂设计
Struct Chem. 2022;33(6):2155-2168. doi: 10.1007/s11224-022-02031-w. Epub 2022 Aug 24.
8
The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus.新型冠状病毒主要蛋白酶作为植物化学物质抗冠状病毒的靶点
Plants (Basel). 2022 Jul 17;11(14):1862. doi: 10.3390/plants11141862.
9
Comprehensive fitness landscape of SARS-CoV-2 M reveals insights into viral resistance mechanisms.SARS-CoV-2 M 的综合适应景观揭示了病毒耐药机制的见解。
Elife. 2022 Jun 20;11:e77433. doi: 10.7554/eLife.77433.
10
Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea compounds in vitro.各种 PET 瓶装日本绿茶及其茶类成分在体外抗 SARS-CoV-2 的活性。
Arch Virol. 2022 Jul;167(7):1547-1557. doi: 10.1007/s00705-022-05483-x. Epub 2022 May 24.